1Stahel R, Ginsberg R, Havemann K, et al. Staging and prognostic factors in small cell lung cancer: a consensus report [J]. Lung Cancer, 1989, 5: 119-126.
2Johnson D H, Einborn L H, Roth B J, et al. Random- ized study of cyclophosphamide, doxornbicin, and vin- cristine versus etoposide and cisplatin versus alternatior of these two regimens in extensive small - cell lung canc- er: a phase llI trial of the Southeastern Cancer Study Group [J]. J Clin Oncol, 1992, 10(2) : 282 -291.
3Pujol J L, Carestia L, Daurs J P. Is there a case for cisplatin in the treatment of small - cell lung cancer? A meta - analysis of randomized trials of a cisplatin - con- taining regimen versus a regimen without this alkylating agent [J]. Br J Cancer, 2000, 83(1): 8- 15.
4Skarlos D V, Samantas E, Kosmidis P, et al. Random- ized comparison of etoposide - cisplatin vs. etoposide - carboplatin and irradiation in small - cell lung cancer. A Hellenic Co -operative Oncology Group study [ J]. Ann Oncol, 1994, 5(7): 601 -607.
5Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etopnside plus cisplatin for extensive small -cell lung cancer [ J]. N Engl J Med, 2002, 346(2): 85-91.
6Hanna N, Bunn P A Jr, Langer C, et al. Randomized phase III trial comparing irinotecarr/cisplatin with etopo- side/cisplatin in patients with previously untreated ex- tensive- stage disease small -cell lung cancer [ J ]. J Clin Oncol, 2006, 24(13) : 2038 - 2043.
7Lara P N Jr, Natale R, Crowley J, et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive - stage small - cell lung cancer: clinical and pharmacogenomic results from SWOG S0124 [ J]. J Clin Oncol, 2009, 27(15): 2530-2535.
8Schnfittel A, Sebastian M, Fischervon Weikersthal L, et a/. A German mtdticenter, randomized phase III trial com- paring irinotecan - carboplatin with etoposide - carboplatin as first -line therapy for extensive -disease small -cell lung cancer [J]. Am, Oncol, 2011, 22(8): 1798-1804.
9Fink T H, Huber R M, Heigener D F, et al. Topote- can/cisplatin compared with cisplatin/etoposide as first - line treatment for patients with extensive disease small -cell lung cancer: final results of a randomized phase III trial[J]. J Thorac Oncol. 2012, 7(9) :1432 - 1439.
10Socinski M A, Weissman C, Hart L L, et al. Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive- stage small -cell lung cancer I l ]- J Clin Oncol, 2006, 24(30): 4840 -4847.
